Vertex Pharmaceuticals Stock Soaring: Is More Upside Ahead?
Vertex Pharmaceuticals has climbed to fresh highs, fueled by a robust cystic fibrosis portfolio and strong cash flow....
An overview of the major forces behind stock index movements, with guidance on tracking catalysts and assessing risk.
21,624 articlesVertex Pharmaceuticals has climbed to fresh highs, fueled by a robust cystic fibrosis portfolio and strong cash flow....
A sharp, near-$99 million exit from this cybersecurity stock has analysts buzzing about a possible shift in investor ...
Citigroup has quietly strengthened its fundamentals while stock performance has turned a corner. This guide breaks do...
July markets bring attention to enduring brands and steady income. Coca-Cola's blend of dividend discipline, pricing ...
A director sold 20,000 shares of First Merchants Corp in a move totaling about $835k. This article explains why insid...
Datadog's CEO recently sold a sizable block of shares. This article breaks down the numbers, explains why insiders se...
When planet fitness stock plunged after the latest earnings, investors suddenly faced a tough question: buy the dip o...
Oracle stock plummeted first as AI ambitions collided with debt and customer risk. This article breaks down the why, ...
Nvidia stock has hit a new all-time high as AI demand accelerates. This article breaks down the drivers behind the ra...
A disciplined look at AMEX shares through the lens of value, growth, and risk. Learn how to judge whether american ex...
Cava Group stunned investors with a standout first-quarter performance, sending the stock higher. But a quick rally d...
Archer Aviation stock just slipped below the $5 mark, prompting a re-evaluation of its long-term potential. This arti...